Categories: News

NYSE Content Advisory: Pre-Market Update + AstraZeneca Climbs Nearly 1% After Historic NYSE Transfer

NEW YORK, Feb. 3, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Ashley Mastronardi delivers the pre-market update on February 3rd

- Advertisement -
  • Stocks are mixed as investors track a heavy week of corporate earnings — including reports from NYSE‑listed Pfizer, Eaton, Uber, and Eli Lilly — while labor data is disrupted by the postponement of Friday’s January Jobs Report due to the partial government shutdown.
  • With government data delayed, market attention is shifting to private‑sector indicators and corporate outlooks to gauge the strength of the U.S. economy.
  • NYSE-listed AstraZeneca scored a winning debut on the NYSE during Monday’s session, climbing 0.7%. The firm began trading on the exchange, marking the largest company transfer by market capitalization in NYSE history.

Opening Bell
Oracle Corporation (NYSE: ORCL) rings the Opening Bell

- Advertisement -

Closing Bell
Tyler Technologies (NYSE: TYL) celebrates its 60th birthday

- Advertisement -

Click here to check out Industry’s time at the NYSE

- Advertisement -

Video – https://mma.prnewswire.com/media/2875962/NYSE_Market_Update_Feb_3.mp4 
Logo – https://mma.prnewswire.com/media/2581322/5749890/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–astrazeneca-climbs-nearly-1-after-historic-nyse-transfer-302677699.html

- Advertisement -

Recent Posts

Dewpoint Therapeutics Doses First Patient in Phase 1a/2a Trial DPTX3186 for the Treatment of Advanced Solid Tumors, Focused on Gastric Cancer

DPTX3186, a first-in-class beta-catenin condensate modulator, received Orphan Drug Designation and Fast Track Designation from…

2 hours ago

Novo Nordisk files annual report with the SEC

Bagsværd, Denmark, 4 February 2026 – Novo Nordisk A/S has filed its Annual Report 2025…

2 hours ago

Adial Applauds Congressional Directive Advancing Alternative Clinical Trial Endpoints for Substance Use Disorders, Strengthening Regulatory Path for AD04

February 04, 2026 09:35 ET  | Source: Adial Pharmaceuticals, Inc GLEN ALLEN, Va., Feb. 04,…

2 hours ago

Patton Acquires Practical Technologies Inc. (PTI) Creating Comprehensive Electronics Manufacturing Hub in Maryland

Patton®... Let's Connect! The liaison creates a powerful combination of manufacturing capabilities that significantly expands…

6 hours ago

ChipMOS Schedules Fourth Quarter and Full Year 2025 Financial Results Conference Call

February 04, 2026 05:00 ET  | Source: ChipMOS TECHNOLOGIES INC. HSINCHU, Taiwan, Feb. 04, 2026…

6 hours ago

Himax Industry-Leading OLED Touch IC Enters Mass Production for IT Applications Elevating the Integrated Display and Touch Experience

Industry-Leading Signal Processing and Algorithms Deliver Precise and Low Touch-Display Interference Across a Wide Range…

6 hours ago